Tag: Cancer
Ipsen’s $247M Epizyme acquisition brings approved cancer drug & more in...
Ipsen has been reshaping its drug lineup by striking deals and its latest one is a $247 million agreement to acquire Epizyme, a cancer...
Merck scraps Keytruda lung cancer trial adding Bristol Myers’ Yervoy. What...
Merck’s Keytruda is without doubt the king in previously untreated non-small cell lung cancer, but the company wanted to see whether adding another immuno-oncology agent...
Imfinzi maker AstraZeneca’s ‘Notes’ campaign delivers encouragement to lung cancer patients
Lung cancer diagnosis and treatment are tough enough in the best of times. AstraZeneca’s new campaign aims to help patients going through both, at a...
Watch out, Merck: FDA grants Regeneron, Sanofi’s Libtayo priority review for...
One month after Regeneron and Sanofi posted impressive data from a phase 3 trial of their PD-1 inhibitor Libtayo in first-line non-small cell lung...
AstraZeneca, Daiichi’s Enhertu steps into the FDA’s fast lane for new...
AstraZeneca and Daiichi Sankyo are rapidly gaining traction for their Enhertu in HER2-positive breast cancer. Next up? An early chance at expanding the blockbuster-to-be into...
Merck, plagued by limited supply of bladder cancer drug, will build...
During its years as sole producer of a difficult-to-make cancer med in high demand, Merck & Co.'s limited capacity has hamstrung its efforts to...
Early-stage nano-carrier uses miRNA to deploy cancer meds on contact with...
Cancer cells could play a key role in the delivery of tumor-fighting drugs, thanks to a new DNA transport system that keeps its therapeutic...
Bristol Myers’ Opdivo clears signs of lung cancer in first-in-class pre-surgery...
Bristol Myers Squibb’s Opdivo may not be the most popular immunotherapy for treating metastatic non-small cell lung cancer, but it’s now the first to report...
ESMO: Merck’s Keytruda-chemo combo shows survival ‘trend,’ but can’t top chemo...
Merck’s Keynote-361 study in newly diagnosed metastatic bladder cancer asked a key question: Could adding Keytruda to chemo improve on chemo, the standard of...
Pfizer launches first-ever breast cancer radio with TV journo Meredith Vieira...
Pfizer’s newest breast cancer awareness effort comes with its own streaming radio station.
The multichannel “Find Your MBC Voice” campaign launched Monday with a first-of-its-kind station, WMBC, programmed solely...
